Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MEDI-0457 by AstraZeneca for Human Papillomavirus (HPV) Associated Cancer: Likelihood of Approval
MEDI-0457 is under clinical development by AstraZeneca and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer. According to...
MEDI-0457 by AstraZeneca for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
MEDI-0457 is under clinical development by AstraZeneca and currently in Phase II for Head And Neck Squamous Cell Carcinoma (HNSC)....
MEDI-0457 by AstraZeneca for Glioblastoma Multiforme (GBM): Likelihood of Approval
MEDI-0457 is under clinical development by AstraZeneca and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...